Differential adeno-associated virus mediated gene transfer to sensory neurons following intrathecal delivery by direct lumbar puncture.

[1]  P. Aebischer,et al.  Recombinant adeno-associated virus serotype 6 (rAAV2/6)-mediated gene transfer to nociceptive neurons through different routes of delivery , 2009, Molecular pain.

[2]  J. Morrison,et al.  Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain , 2008, Proceedings of the National Academy of Sciences.

[3]  I. Nagy,et al.  Neurochemical characterization of insulin receptor‐expressing primary sensory neurons in wild‐type and vanilloid type 1 transient receptor potential receptor knockout mice , 2007 .

[4]  I. Nagy,et al.  Neurochemical characterization of insulin receptor‐expressing primary sensory neurons in wild‐type and vanilloid type 1 transient receptor potential receptor knockout mice , 2007, The Journal of comparative neurology.

[5]  C. M. Flores,et al.  Critical evaluation of the colocalization between calcitonin gene-related peptide, substance P, transient receptor potential vanilloid subfamily type 1 immunoreactivities, and isolectin B4 binding in primary afferent neurons of the rat and mouse. , 2007, The journal of pain : official journal of the American Pain Society.

[6]  B. Hyman,et al.  Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain , 2006, Neuroscience.

[7]  M. Kay,et al.  The 37/67-Kilodalton Laminin Receptor Is a Receptor for Adeno-Associated Virus Serotypes 8, 2, 3, and 9 , 2006, Journal of Virology.

[8]  R. Samulski,et al.  Adeno-Associated Virus Type 2 Contains an Integrin α5β1 Binding Domain Essential for Viral Cell Entry , 2006, Journal of Virology.

[9]  Howard B Gutstein,et al.  Intermittent Lumbar Puncture in Rats: A Novel Method for the Experimental Study of Opioid Tolerance , 2006, Anesthesia and analgesia.

[10]  S. Waxman,et al.  Intense Isolectin-B4 Binding in Rat Dorsal Root Ganglion Neurons Distinguishes C-Fiber Nociceptors with Broad Action Potentials and High Nav1.9 Expression , 2006, The Journal of Neuroscience.

[11]  M. Banck,et al.  Intrathecal gene transfer by adeno-associated virus for pain. , 2005, Current opinion in molecular therapeutics.

[12]  Corinne R. Fantz,et al.  AAV2/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  K. Iwabuchi,et al.  Hepatocyte Growth Factor Receptor Is a Coreceptor for Adeno-Associated Virus Type 2 Infection , 2005, Journal of Virology.

[14]  R. Samulski,et al.  Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  Giovanni Di Pasquale,et al.  Identification of PDGFR as a receptor for AAV-5 transduction , 2003, Nature Medicine.

[16]  C. Fairbanks.  Spinal delivery of analgesics in experimental models of pain and analgesia. , 2003, Advanced drug delivery reviews.

[17]  L. Huang,et al.  Adeno-associated viral transfer of opioid receptor gene to primary sensory neurons: A strategy to increase opioid antinociception , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Kotin,et al.  Immunological Aspects of Recombinant Adeno-Associated Virus Delivery to the Mammalian Brain , 2002, Journal of Virology.

[19]  J. Simpson,et al.  Glial Cell Line-Derived Neurotrophic Factor is a Survival Factor for Isolectin B4-Positive, but not Vanilloid Receptor 1-Positive, Neurons in the Mouse , 2002, The Journal of Neuroscience.

[20]  M. Tuszynski,et al.  Chronic intrathecal infusions after spinal cord injury cause scarring and compression , 2001, Microscopy research and technique.

[21]  M. Welsh,et al.  Binding of Adeno-associated Virus Type 5 to 2,3-Linked Sialic Acid Is Required for Gene Transfer* , 2001, The Journal of Biological Chemistry.

[22]  M. Iadarola,et al.  In vivo control of NMDA receptor transcript level in motoneurons by viral transduction of a short antisense gene. , 2001, Brain research. Molecular brain research.

[23]  F. Porreca,et al.  Nerve injury-induced tactile allodynia is mediated via ascending spinal dorsal column projections , 2001, Pain.

[24]  W. Low,et al.  In vivo transduction of cerebellar Purkinje cells using adeno-associated virus vectors. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  T. Brennan,et al.  Lumbar catheterization of the subarachnoid space with a 32‐gauge polyurethane catheter in the rat , 2000, European journal of pain.

[26]  M. Iadarola,et al.  A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain. , 1999, Human gene therapy.

[27]  Keyun Qing,et al.  Adeno-associated virus 2 co-receptors?-first reply , 1999, Nature Medicine.

[28]  R. North,et al.  P2X3 is expressed by DRG neurons that terminate in inner lamina II , 1998, The European journal of neuroscience.

[29]  E. Neuwelt,et al.  Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. , 1998, Neurosurgery.

[30]  R. Samulski,et al.  Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions , 1998, Journal of Virology.

[31]  J. Eichhorn,et al.  Decreased Paralysis and Better Motor Coordination with Microspinal Versus PE10 Intrathecal Catheters in Pain Study Rats , 1997, Anesthesia and analgesia.

[32]  A. Bollen,et al.  Intrathecal Catheterization in the Rat: Improved Technique for Morphologic Analysis of Drug-induced Injury , 1996, Anesthesiology.

[33]  K. Hole,et al.  Lumbar catheterization of the spinal subarachnoid space in the rat , 1996, Journal of Neuroscience Methods.

[34]  A. Eschalier,et al.  A method to perform direct transcutaneous intrathecal injection in rats. , 1994, Journal of pharmacological and toxicological methods.

[35]  G. Wilcox,et al.  Intrathecal morphine in mice: a new technique. , 1980, European journal of pharmacology.

[36]  T. Jessell,et al.  Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo , 1980, Nature.

[37]  A. Levin,et al.  Treatment of increased intracranial pressure: a comparison of different hyperosmotic agents and the use of thiopental. , 1979, Neurosurgery.